Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -8716.77% is 3338% below its 5-year average of -253.54%, around the middle of its 5-year range (-24356.17%–132.43%).
30.05% below its 12-month average of -6702.41%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2543.34%.
NET PROFIT MARGIN
-8716.77%
NET PROFIT MARGIN AVG TTM
-6702.41%
NET PROFIT MARGIN AVG 3Y
-815.72%
NET PROFIT MARGIN AVG 5Y
-253.54%
NET PROFIT MARGIN AVG 10Y
-766.77%
NET PROFIT MARGIN AVG 15Y
-827.66%
NET PROFIT MARGIN AVG 20Y
-346.08%
CURRENT VS TTM AVG
-30.05%
CURRENT VS 3Y AVG
-968.60%
CURRENT VS 5Y AVG
-3338.02%
CURRENT VS 10Y AVG
-1036.82%
CURRENT VS 15Y AVG
-953.18%
CURRENT VS 20Y AVG
-2418.70%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 564 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Vyome Holdings, Inc.
Market Cap
$13.48M
Net Profit Margin
-8716.77%
TTM Avg
-6702.41%
3Y Avg
-815.72%
5Y Avg
-253.54%
Market Cap
$13.23M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.73M
Net Profit Margin
-48.94%
TTM Avg
-40.16%
3Y Avg
-67.25%
5Y Avg
-58.35%
Market Cap
$12.58M
Net Profit Margin
-804.37%
TTM Avg
-21365.78%
3Y Avg
-11028.80%
5Y Avg
-7352.54%
Market Cap
$14.43M
Net Profit Margin
-651.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.42M
Net Profit Margin
-6.88%
TTM Avg
-8.42%
3Y Avg
-15.06%
5Y Avg
-13.62%
Market Cap
$11.87M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$15.18M
Net Profit Margin
-153.28%
TTM Avg
-93.42%
3Y Avg
-97.51%
5Y Avg
-105.13%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vyome Holdings, Inc. (HIND) | $13.48M | -8716.77% | -6702.41% | -815.72% | -253.54% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| IN8bio, Inc. (INAB)vs › | $13.91M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cytosorbents Corporation (CTSO)vs › | $12.73M | -48.94% | -40.16% | -67.25% | -58.35% |
| Dare Bioscience, Inc. (DARE)vs › | $12.58M | -804.37% | -21365.78% | -11028.80% | -7352.54% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.43M | -651.27% | 0.00% | 0.00% | 0.00% |
| IRIDEX Corporation (IRIX)vs › | $12.42M | -6.88% | -8.42% | -15.06% | -13.62% |
| Lantern Pharma Inc. (LTRN)vs › | $11.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.18M | -153.28% | -93.42% | -97.51% | -105.13% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.27M | 0.00% | 0.00% | 0.00% | -2405.08% |
Operating Margin
-859.2%
Net Profit Margin
-8716.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2543.34% |
| 2026-03-31 | -3048.05% |
| 2025-12-31 | -3352.75% |
| 2025-09-30 | -24356.17% |
| 2025-06-30 | -211.76% |
| 2025-03-31 | 132.43% |
| 2024-12-31 | -97.56% |
| 2024-09-30 | -68.98% |
| 2024-06-30 | -81.17% |
| 2024-03-31 | -112.81% |
| 2023-12-31 | -85.67% |
| 2023-09-30 | -163.99% |
| 2023-06-30 | -154.97% |
| 2023-03-31 | -116.40% |
| 2022-12-31 | -534.15% |
| 2022-09-30 | -435.53% |
| 2022-06-30 | -326.56% |
| 2022-03-31 | -336.68% |
| 2021-12-31 | -1128.52% |
| 2021-09-30 | -477.32% |
| 2021-06-30 | -110.57% |
| 2021-03-31 | -151.32% |
| 2020-12-31 | -266.25% |
| 2020-09-30 | -143.78% |
| 2020-06-30 | -211.75% |
| 2020-03-31 | -154.57% |
| 2019-12-31 | -618.69% |
| 2019-09-30 | -818.04% |
| 2019-06-30 | -357.75% |
| 2019-03-31 | -145.61% |
| 2018-12-31 | 2053.83% |
| 2018-09-30 | -1999.91% |
| 2018-06-30 | -5395.24% |
| 2018-03-31 | -1182.47% |
| 2017-12-31 | -1211.20% |
| 2017-09-30 | -2775.87% |
| 2017-06-30 | -7350.29% |
| 2017-03-31 | -18398.63% |
| 2016-12-31 | -3125.06% |
| 2016-09-30 | -2197.89% |
| 2016-06-30 | -1809.84% |
| 2016-03-31 | -10289.95% |
| 2015-12-31 | -4544.30% |
| 2015-09-30 | -6485.42% |
| 2015-06-30 | -9371.85% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | -2635.11% |
| 2012-03-31 | -4576.21% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
